---
title: "Causal integration of multi-omics data with prior knowledge to generate mechanistic hypotheses"
date: last-modified
categories: [Multi-omics, Systems Biology, Causal Inference, Signaling Networks, Phosphoproteomics, Transcriptomics, Metabolomics, Bioinformatics]
---

**PubMed:** [33502086](https://pubmed.ncbi.nlm.nih.gov/33502086/)
**DOI:** [10.15252/msb.20209703](https://doi.org/10.15252/msb.20209703)
**Overview generated by:** Gemini 2.5 Flash, 27/11/2025

## Background and Objective

The rise of **multi-omics** technologies provides vast datasets that capture different layers of molecular information (e.g., phosphorylation, transcription, metabolism). However, methods for integrating these diverse data types to systematically extract **mechanistic hypotheses**—specifically, how a change in one molecular layer causally affects another—are limited.

This paper introduces **COSMOS (Causal Oriented Search of Multi-Omics Space)**, a novel computational method designed to:
1.  Integrate quantitative data from three omics layers: **phosphoproteomics**, **transcriptomics**, and **metabolomics**.
2.  Combine this data with extensive **prior knowledge** contained within signaling, metabolic, and gene regulatory networks.
3.  Infer the **causal relationships** between molecular activities across these layers to generate mechanistic hypotheses.

## Methods: The COSMOS Framework

### Causal Integration Principle
COSMOS's core strength lies in its use of a large, curated **prior knowledge network (PKN)** that encompasses relationships between various molecular entities, including transcription factors, kinases, genes, and metabolites. The method works by performing two key causal steps:

1.  **Activity Inference:** COSMOS first calculates the estimated activity of key molecular regulators from the measured omics data:
    * **Kinase Activity** (from phosphoproteomics)
    * **Transcription Factor (TF) Activity** (from transcriptomics)
    * **Enzyme/Pathway Activity** (from metabolomics)
2.  **Causal Scoring and Hypothesis Generation:** The inferred activity changes are then mapped onto the PKN. COSMOS calculates a **causal score** for every potential regulatory link between a regulator (e.g., a kinase) and its target (e.g., a TF or a metabolite) by evaluating whether the measured change in the regulator's activity is consistent with the measured change in its target's activity, considering the known network topology.

### Application: Renal Cell Carcinoma (RCC)
COSMOS was applied to multi-omics data from a drug screen on **Clear Cell Renal Cell Carcinoma (ccRCC)** cells treated with various anti-cancer compounds. This allowed the authors to investigate how drug perturbations causally rewire the signaling, gene regulation, and metabolic networks of cancer cells.

## Key Results and Mechanistic Hypotheses

### Network Rewiring in ccRCC
COSMOS successfully inferred activity changes in known regulatory pathways, demonstrating the effect of drug perturbations on the signaling, transcriptional, and metabolic machinery of the cancer cells.

### Causal Hypotheses Generated
The method generated specific, testable **mechanistic hypotheses** that connect the omics layers:
1.  **Signaling to Transcription (Kinase → TF):** COSMOS identified the **TSSK4 kinase** as a causal regulator of the **ZHX2 transcription factor** following treatment with a CDK inhibitor. This suggested a specific kinase-TF cascade that could be important for therapeutic response.
2.  **Transcription to Metabolism (TF → Metabolite):** The method also revealed a causal link from the **ZHX2 TF** to the regulation of **GAPDH enzyme activity** (a key player in glycolysis), which in turn regulated specific metabolites like **pyruvate**. This closed the loop, linking signaling through transcription to metabolic output.
3.  **Discovery of Novel Kinases:** Through its integration, COSMOS implicated several previously uncharacterized kinases (e.g., **CDK11**) as potential drivers of the transcriptional response to drug treatment, suggesting novel targets for further investigation.

## Conclusions and Significance

COSMOS represents a significant advance in **systems biology** by offering a robust, transparent, and biologically constrained approach to **causal integration of multi-omics data**.

By leveraging extensive prior knowledge, it moves beyond simple association to generate specific, directional, and testable **mechanistic hypotheses** that bridge the gap between different omics layers. This capability is critical for understanding complex diseases like cancer and for accelerating the discovery of novel therapeutic targets and biomarkers.